Stack Compatibility Guide
Most researchers running multiple compounds are asking the wrong question. The question is not what else to add. The question is whether what you are already running is creating interference.
The Stack Compatibility Guide covers the four categories every compound combination falls into. Each one is defined by mechanism, meaning how a compound actually works at the receptor level, not by its name or how commonly it is discussed. Understanding which category a combination sits in before making a protocol change is the difference between adding leverage and adding cost.
Researchers who are already running a protocol and not seeing the results the compounds should produce.
Researchers who have added a second or third compound and cannot tell which one is responsible for what they are seeing or not seeing.
Researchers who have stalled and are considering adding something new before identifying whether the current configuration is already creating interference.
Anyone who wants to understand why the same compound can perform completely differently depending on what else is running alongside it.
Every compound combination falls into one of these. The mechanism reference table inside the guide tells you exactly where each combination lands.
| Category | What it means | Example |
|---|---|---|
| Additive | Different mechanisms, different problems. Each compound does something the other cannot. | CJC-1295 no DAC + Ipamorelin |
| Conditional | Additive only when the right problem is confirmed first. Without the diagnosis, it adds cost. | Retatrutide + MOTS-c |
| Either/Or | Not a stack question. A diagnosis decision. Running both before identifying which failure point exists adds cost without leverage. | MOTS-c vs SS-31 |
| Redundant | Same pathway, stronger feedback limitation. Neither compound performs the way it would alone. | Tesamorelin + CJC-1295 |
Two compounds competing for the same receptor. Remove the redundant compound and re-establish a clean baseline before adding anything else.
Too many variables running simultaneously to produce a conclusion you can trust. Hold stable for a minimum of four weeks before any change.
You may be running the right compounds for a pattern you have not confirmed exists. The next step is diagnosis, not addition.
Different mechanisms, different problems, clear individual responses. If results have stalled, the limiting variable is somewhere else in the protocol.
This guide identifies whether a stack conflict exists and gives you the framework to act on it. There is a category of stall it cannot reach — where two variables are active at the same time, or where the stack looked correct but a second variable was running underneath the whole time. That pattern requires more diagnostic resolution than any general framework can provide. That is what the Protocol Audit is designed for.
For educational and research purposes only | Not medical advice | Not for human use guidance | Project Theo
Styled With